Document Type : Original Article
Authors
1 Department of Health Information Technology and Management, School of Medical Management and Information Sciences, Isfahan University of Medical Sciences, Hezarjerib Avenue, Isfahan, Iran
2 Student in Health Information Technology, School of Medical Management and Information Sciences, Isfahan University of Medical Sciences, Hezarjerib Avenue, Isfahan, Iran
Abstract
BACKGROUND: The minimum data set (MDS) is one of the important steps in the development of
health care information systems. According to the Ministry of Health in Iran, a central and national
registry along with Parkinson’s MDS (PMDS) has not yet existed. So, this research was conducted
to establish a PMDS in Iran.
MATERIAL AND METHODS: This study was a descriptive–comparative method, which was done
in 2019–2021 in four phases: (1) determining data elements related to Parkinson’s disease in Iran
and selected countries; (2) extracting and categorizing the data elements; (3) making a PMDS
draft; (4) evaluating a draft by Delphi technique. The research population was the MDS in Australia,
Canada, the United States of America, and Iran. After extracting the data elements of Parkinson’s
disease from various resources, the primary draft PMDS was developed. Then, the research group
divided it into two categories (administrative and clinical). After that, it was sent to 50 healthcare
professionals for validation by the Delphi method.
RESULTS: Following the results of the two rounds of Delphi technique, Finally, PMDS was established
including a total of 223 data elements in two categories: administrative and clinical with 72 and 151,
respectively. Every category included 10 and 14 subcategories.
CONCLUSION: The first and the most important step for standardization of data collection nationally
is creating MDS. Due to the necessity of the existence of PMDS, a complete list of PMDS was
established for collecting data on Parkinson’s patients.
Keywords
Comparing With Iran. Salmand: Iran. J. Ageing. 2008; 3 (1):68‑77.
URL: http://salmandj.uswr.ac.ir/article‑1‑87‑en.html.
2. Safdari R, Sadeghi F, Mohammadiazar M. Aged Care and Services
Programs in Iran: Looking at the Performance of Relevant
Organizations. payavard. 2016; 10 (2):155‑166. URL: http://
payavard.tums.ac.ir/article‑1‑6046‑en.html.
3. Burn D. Parkinson’s disease: An overview. Pharm J 2000;264:333‑7.
4. Emamalizadeh B, Movafagh A, Akbari M, Kazeminasab S,
Fazeli A, Motallebi M, et al. RIT2, a susceptibility gene for
Parkinson’s disease in Iranian population. Neurobiol Aging
2014;35:e27‑8.
5. Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V,
Pedersen L, Sørensen HT. The Danish national patient registry:
A review of content, data quality, and research potential. Clin
Epidemiol 2015;7:449‑90.
6. Ajami S, Hosseini M. A comparative study on the features of
Iran health population information management system with
the United Nations standards. J Health Adm 2013;15 (50):18‑30.
https://www.sid.ir/fa/journal/ViewPaper.aspx?id=196701.
7. ArastooAA, NickbakhtM, GhasemzadehR, AziziA, ZahednejadS,
Latifi SM. Standardization of data elements of audiology records:
A suitable model for Iran. Audiology 2012;21:26‑37.
8. Abdelhak M, Grostick S, Hanken MA. Health Information:
Management of A Strategic Resource. 4th Edition, Elsevier Health
Sciences: Philadelphia: 2014.
9. Sayles NB. Health Information Management Technology an
Applied Approach. American Health Information Management
Association press; Chicago: 2012.
10. Xue JH, Hu ZP, Lai P, Cai DQ, Wen ES. The 100 most‑cited articles
in Parkinson’s disease. Neurol Sci 2018;39:1537‑45.
11. Ajami S, Askarianzadeh M, Mortazavi M. Developing a
provisional and national renal disease registry for Iran. J Res Med
Sci 2015;20:244‑9.
12. Ajami S, Askarianzadeh M, Saghaeiannejad‑Isfahani S,
Mortazavi M, Ehteshami A. Comparative study on the National
renal disease registry in America, England, and Iran. J Edu Health
Promot 2014;3:56.
13. Ajami S, Lamoochi P. Comparative study on National burn
registry in America, England, Australia and Iran. J Edu Health
Promot 2014;3:84.
14. Ojo OO, Abubakar SA, Iwuozo EU, Nwazor EO, Ekenze OS,
Farombi TH, et al. The Nigeria Parkinson disease registry: Process,
profile, and prospects of a collaborative project. Mov Disord
2020;35:1315‑22.
15. Kim HM, Leverenz JB, Burdick DJ, Srivatsal S, Pate J,
Hu SC, et al. Diagnostic validation for participants in the
Washington state Parkinson disease registry. Parkinsons Dis
2018;2018:3719578.
16. Daneault JF, Vergara‑Diaz G, Parisi F, Admati C, Alfonso C,
Bertoli M, et al. Accelerometer data collected with a minimum
set of wearable sensors from subjects with Parkinson’s disease.
Sci Data 2021;8:48.
)